Release Date: August 15, 2025
Expiration Date: August 15, 2026
Activity Overview
This Burst CME is a video-based program in which an expert faculty presents and discusses the latest in the management of chronic kidney disease (CKD) and fluid overload. The content focuses on the guidelines for the treatment of CKD, the various therapies for the management of CKD, and CKD-associated fluid overload. This unique format is designed to accommodate the busy clinician and provide a quick, go-to resource on the topic.
Target Audience
This educational activity is directed toward nephrologists, cardiologists, nurse practitioners, physician assistants, registered nurses, and other specialty health care practitioners involved in the multidisciplinary management of chronic kidney disease (CKD) and its associated cardiac comorbidities.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss evidence regarding current and emerging therapies to manage fluid overload in patients with CKD and cardiac comorbidities
- Develop treatment plans for fluid overload in patients with CKD and cardiac comorbidities
Suneel Udani, MD
Consulting Physician
Medical Director
Nephrology Associates of Northern Illinois and Indiana Research
Hinsdale, IL
Disclosures: Consultant: Amgen, Inc; Boehringer Ingelheim International GmbH; Calliditas Therapeutics; George Clinical, Novartis; scPharmaceuticals; Travere Therapeutics; Speaker Bureau: Amgen, Inc; Boehringer Ingelheim International GmbH; Novartis; Travere Therapeutics; Other: Apellis Pharmaceuticals; AstraZeneca; Bayer; Dimerix; ENYO; Goldfinch Bio; Mallinckrodt Pharmaceuticals; Novartis; Travere Therapeutics; Vertex Pharmaceuticals Incorporated.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.